Safety and Tolerability of Open-Labeled Iloperidone in Adolescents

Who May Qualify: - Patient is willing and able to provide assent and willing to complete all aspects of the study - Patient's parent or legal guardian willing and able to provide consent - Male or female patients 12 through 17 years of age (inclusive) - Clinical diagnosis of either schizophrenia or bipolar I disorder Who Should NOT Join This Trial: - Use of other investigational drugs at the time of enrollment, or within 30 days or 5 half-lives of enrollment, whichever is longer - A positive test for drugs of abuse Always talk to your doctor about whether this trial is right for you.